Contraindication/Precautions
Contraindicated in:
Hypersensitivity to abciximab or murine (mouse) protein
Active internal bleeding
Recent significant GI or GU bleeding (within 6 wk)
History of CVA (within 2 yr) or CVA with neurologic sequelae
History of bleeding disorder
Recent (within 7 days) oral anticoagulant therapy (PT >=1.2 times control)
Platelet count <100,000 cells/mm³
Recent trauma or major surgery (within 6 wk)
Intracranial neoplasm
Aneurysm or AV malformation
Severe uncontrolled hypertension
History of vasculitis
Concurrent use of another parenteral GP IIb/IIIa inhibitor
Recent or concurrent dextran therapy
Use Cautiously in: Patients weighing <75 kg or >65 yr (increased risk of bleeding)
History of previous GI pathology
Concurrent thrombolytic or heparin therapy
PCI within 12 hr of onset of MI symptoms or PCI procedure lasting >70 min
OB: Lactation: Pedi: Safety not established
abciximab is a sample topic found in Davis's Drug Guide. All other sections of this record are viewable by clicking on the index in the left column, or by clicking on "Display all Sections" in the "Content Manager".
To find other Davis's Drug Guide topics, please login or purchase a subscription.